CAD3.91
3.22% yesterday
Toronto, Apr 16, 10:00 pm CET
ISIN
CA94947L1022
Symbol
WELL

WELL Health Technologies Target price 2025 - Analyst rating & recommendation

WELL Health Technologies Classifications & Recommendation:

Buy
92%
Hold
8%

WELL Health Technologies Price Target

Target Price CAD8.27
Price CAD3.91
Potential
Number of Estimates 13
13 Analysts have issued a price target WELL Health Technologies 2026 . The average WELL Health Technologies target price is CAD8.27. This is higher than the current stock price. The highest price target is
CAD11.00 181.33%
register free of charge
, the lowest is .
A rating was issued by 13 analysts: 12 Analysts recommend WELL Health Technologies to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the WELL Health Technologies stock has an average upside potential 2026 of . Most analysts recommend the WELL Health Technologies stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million CAD 919.69 1,208.48
18.51% 31.40%
EBITDA Margin 5.76% 13.14%
56.15% 128.27%
Net Margin 3.52% 1.86%
47.17%

13 Analysts have issued a sales forecast WELL Health Technologies 2025 . The average WELL Health Technologies sales estimate is

CAD1.2b
Unlock
. This is
31.40% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CAD1.4b 49.80%
Unlock
, the lowest is
CAD1.1b 20.15%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CAD920m 18.51%
2025
CAD1.2b 31.40%
Unlock
2026
CAD1.4b 13.37%
Unlock
2027
CAD1.6b 16.04%
Unlock
2028
CAD1.7b 6.38%
Unlock

12 Analysts have issued an WELL Health Technologies EBITDA forecast 2025. The average WELL Health Technologies EBITDA estimate is

CAD159m
Unlock
. This is
200.04% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CAD190m 258.90%
Unlock
, the lowest is
CAD149m 180.71%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 CAD52.9m 48.04%
2025
CAD159m 200.04%
Unlock
2026
CAD181m 14.00%
Unlock
2027
CAD194m 6.87%
Unlock
2028
CAD224m 15.80%
Unlock

EBITDA Margin

2024 5.76% 56.15%
2025
13.14% 128.27%
Unlock
2026
13.22% 0.61%
Unlock
2027
12.17% 7.94%
Unlock
2028
13.25% 8.87%
Unlock

6 WELL Health Technologies Analysts have issued a net profit forecast 2025. The average WELL Health Technologies net profit estimate is

CAD22.4m
Unlock
. This is
35.71% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CAD32.4m 7.15%
Unlock
, the lowest is
CAD5.0m 85.72%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CAD32.4m
2025
CAD22.4m 30.76%
Unlock
2026
CAD45.5m 102.77%
Unlock
2027
CAD54.8m 20.55%
Unlock
2028
CAD78.5m 43.18%
Unlock

Net Margin

2024 3.52%
2025
1.86% 47.17%
Unlock
2026
3.32% 78.49%
Unlock
2027
3.45% 3.92%
Unlock
2028
4.64% 34.49%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share CAD 0.13 0.09
30.77%
P/E 44.89
EV/Sales 1.18

6 Analysts have issued a WELL Health Technologies forecast for earnings per share. The average WELL Health Technologies EPS is

CAD0.09
Unlock
. This is
35.71% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CAD0.13 7.14%
Unlock
, the lowest is
CAD0.02 85.71%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CAD0.13
2025
CAD0.09 30.77%
Unlock
2026
CAD0.18 100.00%
Unlock
2027
CAD0.22 22.22%
Unlock
2028
CAD0.32 45.45%
Unlock

P/E ratio

Current 28.42 102.04%
2025
44.89 52.90%
Unlock
2026
22.14 50.68%
Unlock
2027
18.36 17.07%
Unlock
2028
12.83 30.12%
Unlock

Based on analysts' sales estimates for 2025, the WELL Health Technologies stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.51 11.70%
2025
1.18 23.91%
Unlock
2026
1.04 11.79%
Unlock
2027
0.90 13.83%
Unlock
2028
0.84 5.99%
Unlock

P/S ratio

Current 1.08 4.01%
2025
0.85 23.90%
Unlock
2026
0.75 11.79%
Unlock
2027
0.64 13.82%
Unlock
2028
0.60 5.99%
Unlock

Current WELL Health Technologies Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
CORMARK SECURITIES INC.
Locked
Locked
Locked Apr 06 2025
HAYWOOD SECURITIES INC.
Locked
Locked
Locked Mar 30 2025
BEACON SECURITIES
Locked
Locked
Locked Mar 30 2025
STIFEL CANADA
Locked
Locked
Locked Mar 30 2025
VENTUM FINANCIAL CORP.
Locked
Locked
Locked Mar 30 2025
TD COWEN
Locked
Locked
Locked Mar 30 2025
CIBC CAPITAL MARKETS
Locked
Locked
Locked Mar 30 2025
Analyst Rating Date
Locked
CORMARK SECURITIES INC.:
Locked
Locked
Apr 06 2025
Locked
HAYWOOD SECURITIES INC.:
Locked
Locked
Mar 30 2025
Locked
BEACON SECURITIES:
Locked
Locked
Mar 30 2025
Locked
STIFEL CANADA:
Locked
Locked
Mar 30 2025
Locked
VENTUM FINANCIAL CORP.:
Locked
Locked
Mar 30 2025
Locked
TD COWEN:
Locked
Locked
Mar 30 2025
Locked
CIBC CAPITAL MARKETS:
Locked
Locked
Mar 30 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today